Genetic studies of cluster of acute lymphoblastic leukemia cases in Churchill County, Nevada

Environmental Health Perspectives

Volumn 115, Issue 1, 2007, Pages 158-164

  Steinberg, Karen K ^a,d   Relling, Mary V ^b   Gallagher, Margaret L ^a   Greene, Christopher N ^a   Rubin, Carol S ^a   French, Deborah ^b   Holmes, Adrianne K ^a   Carroll, William L ^c   Koontz, Deborah A ^a   Sampson, Eric J ^a   Satten, Glen A ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Arsenic; Children; Cluster; DDE; Enzymes; Genetics; Leukemia; Polymorphism; Tungsten

Indexed keywords

ALDEHYDE OXIDASE; ARSENIC; SULFITE OXIDASE; TUNGSTEN; XANTHINE DEHYDROGENASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLELE; ARTICLE; B CELL LEUKEMIA; CANCER GENETICS; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; LEUKEMOGENESIS; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UNITED STATES;

ADOLESCENT; ADULT; ALDEHYDE OXIDASE; CHILD; CHILD, PRESCHOOL; FEMALE; HAPLOTYPES; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; NEVADA; OXIDOREDUCTASES ACTING ON SULFUR GROUP DONORS; POLYMORPHISM, SINGLE NUCLEOTIDE; XANTHINE DEHYDROGENASE;

EID: 33845969520     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.9025     Document Type: Article

References (31)

1. CDC. 2003a. Cross-Sectional Exposure Assessment of Environmental Contaminants in Churchill County, Nevada-Appendix C Investigation Protocol. Atlanta, GA:Centers for Disease Control and Prevention.
2. CDC. 2003b. The National Report on Human Exposure to Environmental Chemicals. Atlanta, GA:Centers for Disease Control and Prevention. Available: http://www.cdc.gov/exposurereport/ [accessed 31 May 2006].
3. 2. Proc Natl Acad Sci 70:3655-3659.
4. Epstein MP, Satten GA. 2003. Inference on haplotype effects in case-control studies using unphased genotype data. Am J Hum Genet 73;1316-1329.
5. Gardlik S, Rajagopalan KV. 1991. The mechanisms of inactivation of sulfite oxidase by periodate and arsenite. J Biol Chem 266:16627-16632.
6. Garner CD, Stewart LJ. 2002. Tungsten-substituted molybdenum enzymes. In: Molybdenum and Tungsten: Their Roles in Biological Processes (Sigel H, Sigel A, eds). Metal Ions in Biological Systems, Vol 39. New York:Marcel Dekker, 699-726.
7. Gebauer F, Hentze M. W. 2004. Molecular mechanisms of translational control. Nature Rev Mol Cell Biol 5:827-835.
8. James SJ, Basnakian AG, Miller BJ. 1994. In vitro folate deficiency induces deoxynucleotide pool imbalance, apoptosis, and mutagenesis in Chinese hamster ovary cells. Cancer Res 54:5075-5080.
9. Koutsospyros A, Braida W, Christodoulatos C, Dermatas D, Strigul N. 2006. A review of tungsten: from environmental obscurity to scrutiny. J Hazard Mater 136:1-19.
10. Krajinovic M, Sinnett H, Richer C, Labuda D, Sinnett D. 2002. Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int J Cancer 97:230-236.
11. Kunz BA, Kohalmi SE. 1991. Modulation of mutagenesis by deoxyribonucleotide levels. Annu Rev Genet 25:339-359.
12. Look AT. 1997. Oncogenic transcription factors in the human acute leukemias. Science 278:1059-1064.
13. L'vov NP, Nosikov AN, Antipov AN. 2002. Tungsten-containing enzymes. Biochemistry 67:196-200.
14. McHale MC, Smith MT. 2004. Prenatal origin of chromosomal translocations in acute childhood leukemia: implications and future directions. Am J Hematol 75:254-257.
15. Miller AC, Mog S, McKinney L, Luo L, Allen J, Xu J, et al. 2001. Neoplastic transformation of human osteoblast cells to the tumorigenic phenotype by heavy metal-tungsten alloy particles: induction of genotoxic effects. Carcinogenesis 22:115-125.
16. Ng PC, Henikoff S. 2001. Predicting deleterious amino acid substitutions. Genome Res 11:863-874. Available: http://blocks.fhcrc.org/ sift/SIFT.html [accessed 31 May 2006]
17. NTP. Tungsten and Selected Tungsten Compounds. Review of Toxicological Literature. 2003. Research Triangle Park, NC: National Institute of Environmental Health Sciences, National Toxicology Program. Available: http://ntp.niehs.nih.gov/ntp/htdocs/Chem_Background/ExSumPdf/ tungsten.pdf [accessed 31 May 2006].
18. Packer BR, Yeager M, Burdett L, Welch R, Beerman M, Qi L, et al. 2006. SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 1:34 Database issue:D617-D621. Available: http://snp500cancer.nci.nih.gov [accessed 2 June 2006]
19. Pui C-H, Relling MV, Downing JR. 2004. Acute lymphoblastic leukemia. N Engl J Med 350:1535-1548.
20. Ramensky V, Bork P, Sunyaev S. 2002. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30:3894-900. Available: http://genetics.bwh.harvard.edu/pph/ [accessed 31 May 2006]
21. Relling MV, Yang W, Sas S, Cook EH, Rosner GL, Neel M, et al. 2004. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol 22:3930-3936.
22. Romana SP, Poirel H, Leconiat M, Flexor MA, Mauchauffé M, Jonveaux P, et al. 1995. High frequency of 1(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 86:4263-4269.
23. Rubin CS, Holmes AK, Belson MG, Jones RL, Flanders WD, Kieszak SM, et al. 2007. Investigating childhood leukemia in Churchill County, Nevada. Environ Health Perspect 115:151-157.
24. Satten GA, Epstein MP. 2004. Comparison of prospective and retrospective methods for haplotype inference in casecontrol studies. Genet Epidemiol 27:192-201.
25. Skibola CF, Smith MT, Hubbard A, Shane B, Roberts AC, Law GR, et al. 2002. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 99:3786-3791.
26. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA, et al. 1999. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 96:12810-12815.
27. Smith MT, McHale CM, Wiemels JL, Zhang L, Wiencke JK, Zheng S, et al. 2005. Molecular biomarkers for the study of childhood leukemia. Toxicol Appl Pharmacol 206:237-245.
28. Steinmaus C, Lu M, Todd RL, Smith AH. 2004. Probability estimates for the unique childhood leukemia cluster in Fallon, Nevada, and risks near other U.S. military aviation facilities. Environ Health Perspect 112:766-771.
29. Sun FZ, Flanders WD, Yang Q, Khoury MJ. 1999. Transmission disequilibrium test (TDT) when only one parent is available: the 1-TDT. Am J Epidemiol 150:97-104.
30. Tan W-H, Eichler FS, Hoda S, Lee MS, Baris H, Hanley CA, Grant PE, Krishnamoorthy KS, Shih VE. 2000. Isolated sulfite oxidase deficiency: a case report with a novel mutation and review of the literature. Pediatrics 116:757-66.
31. Tocci A, Parolini I, Gabbianelli M, Testa U, Luchetti L, Samoggia P, et al. 1996. Dual action of retinoic acid on human embryonic/fetal hematopoiesis: blockade of primitive progenitor proliferation and shift from multipotent/erythroid/monocytic to granulocytic differentiation program. Blood 87:1728-1736.